IntelliBio
Entry
2019
Hold
4yr
Exit
2023
Who owns IntelliBio?
IntelliBio is a Chinese MedTech company, formerly owned by Cathay Capital, exited in 2023 (exit via Trade Sale). No current private equity owner is on file.
Hand-verified · updated 2026-09-30
Open JSON · CC-BY
Exit Type
Trade Sale
Exit Year
2023
More from Cathay Capital Small Cap III
Other portfolio companies in the same fund.
FranceMore PE-backed in MedTech
Comparable medtech deals from other GPs.
US
GermanyQuestions
Who owns IntelliBio?
IntelliBio was formerly owned by Cathay Capital, exited in 2023. No current private equity owner is on file.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue